Sort   by:  
 Page size 
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownComparison of the real-world effectiveness of vertical versus lateral functional hemispherotomy techniques for pediatric drug-resistant epilepsy: A post hoc analysis of the HOPS study.
Not available
S-EPMC9290517 | biostudies-literature
UnknownSex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation).
Not available
S-EPMC6377059 | biostudies-literature
UnknownEffect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes.
Not available
S-EPMC10734790 | biostudies-literature
UnknownPractical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study.
Not available
S-EPMC9022681 | biostudies-literature
UnknownOral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation.
Not available
S-EPMC9300111 | biostudies-literature
UnknownDMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.
Not available
S-EPMC8351392 | biostudies-literature
UnknownAcute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.
Not available
S-EPMC10907445 | biostudies-literature
UnknownEpidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study.
Not available
S-EPMC10709241 | biostudies-literature
UnknownGlobal Impact of COVID-19 on Stroke Care and IV Thrombolysis.
Not available
S-EPMC8205458 | biostudies-literature
Sort   by:  
 Page size